2022/09/02 by Philipp Stelzhammer, Wolfgang Weber, Stelzhammer, Philipp +9
Medicine · #Acne and Rosacea Treatments and Effects #Antibiotikaverbrauch #Antimicrobial Resistance in Staphylococcus #Dermatologie #Haut- und Weichteilinfekte #Medicine and health #Streptococcal Infections and Treatments #antibiotic consumption #dermatology #skin and soft tissue infections
paper · doi:10.3205/dgkh000419
openalex publication_date 2022/09/02 · openalex created_date 2025/10/10 · openalex updated_date 2026/07/19
Aim: Treatment of bacterial soft tissue infections is an essential part of clinical dermatology, and the choice of antibiotic therapy is often empirical. The aim of this longitudinal retrospective study was to evaluate bacterial epidemiology, resistance patterns and antibiotic consumption in a dermatological inpatient ward. Method: Bacterial isolates and antimicrobial susceptibility testing from a dermatological inpatient ward were recorded retrospectively from 2011 to 2016. The antibiotic consumption was evaluated and given as the assumed defined daily dose [DDD] per 100 days of covering per year. Results: of all isolates. Beta-lactam antibiotics were the most used drugs (14.4, 10.8, and 9.6 DDD/100 for aminopenicillins, cefalexin, and penicillin G), followed by clindamycin (9.0 DDD/100 patient days). Conclusion: In view of the frequency of bacterial soft tissue infections and their need for inpatient treatment with mostly empirically chosen antibiotics, systematic microbiological surveillance should be recommended for dermatological inpatient wards.